Fact CheckerSign in

NCT05145244Recruiting

Copenhagen Master Observational Trial

Copenhagen Master Observational Trial (C-MOT): A Prospective Investigator-initiated Observational Study to Study Biomarkers in Relation to Clinical Outcome in Patients With Non-Small Cell Lung Cancer or Breast Cancer

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

The primary objectives of this prospective non-interventional study (NIS) are to assess and describe outcomes in relation to biomarkers, including whole-genome sequencing (WGS) in patients with non- small cell lung cancer (NSCLC) or breast cancer receiving treatment offered in the clinic (standard of care or included in clinical trials).

Status (registry)
Recruiting
Study type
Observational
Enrollment
2400 (estimated)
First submitted
27 Sept 2021
Start date
1 Aug 2021
Primary completion date
31 Dec 2026
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Diseases
Lung cancer
NCT number
NCT05145244

What you commit to

  • Study type: Observational
  • Planned participants: 2400
  • From 1 Aug 2021 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patient with breast cancer initiating adjuvant systemic therapy
  • In the judgment of the investigator, the patient's life expectancy is fewer than 3 months at the time of diagnosis of NSCLC or breast cancer

Who the study is looking for

  • Patients (≥ 18 years of age) with diagnosis of NSCLC or breast cancer amenable to medical or radiation therapy with curative or palliative intent
  • Evidence of a personally signed and dated informed consent form document indicating that the patient has been informed of all pertinent aspects of the study
  • Able to read and understand Danish
  • Willing and able to complete collection of data including WGS

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rigshospitalet
Coordinator of this site? Confirm its status
CopenhagenDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.